Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announces the introduction of OtoLase, the new otology designated enhancement for the AcuPulse family of products. Specifically designed for enhanced precision and ease of use in middle ear surgery, the innovative OtoLase was showcased at the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF) Annual meeting 2016.
The OtoLase solution, compatible with the AcuPulse DUO laser system, is a combination of reusable fiber and handpieces with different single-use tips, allowing for smooth, individualized and cost effective operation of varied pathologies in the middle ear. Based on clinical studies, otologic procedures with CO2 laser technology have shown superior outcomes compared with other modalities. With the ergonomic and operational design of OtoLase, surgeons are equipped with great precision and excellent visualization allowing them to remove layer-by-layer undesired tissue and enhance clinical outcomes of delicate ear procedures.
“OtoLase has been engineered for safety and ease of use. The air flow system eliminates the laser plume and facilitates visualization, and the aiming beam ensures target accuracy”, says John T. McElveen Jr., M.D from Carolina Ear & Hearing Clinic in Raleigh, North Carolina. “The low profile and thin design allows the surgeon to reach the smallest recesses within the middle ear. This enhanced fiberoptic CO2 laser technology has been worth the wait.”
(Image credit: Lumenis)
The versatile AcuPulse DUO laser system with OtoLase and the wide range of designated accessories, is an upgradable, all-inclusive solution for a range of diverse ear surgery treatments, including otosclerosis, cholesteatoma, tympanoplasty, myringotomy/tympanostomy, scar tissue dissection, acoustic neuroma, and more. The laser system can be used for office and hospital-based procedures.
“With 50-year history of rederfining medical treatments and providing gold standard clinical advances, Lumenis has revolutionized the approach to micro laser surgery with its energy-based technology,” says Tzipi Ozer-Armon, CEO of Lumenis. “By striving to provide innovative tools to improve surgical performance, Lumenis continues to deliver next-generation energy-based solutions for our partners in the medical community and enhance patient care.”
